The International Journal of Biochemistry & Cell Biology
ReviewMuscle type and fiber type specificity in muscle wasting☆
Introduction
Skeletal muscles are heterogeneous both at the level of whole muscles, motor units and constituent muscle fibers. An obvious diversity pertains to the anatomical position of skeletal muscles within the body, their specific shape and pattern of tendon and bone insertions, all properties which dictate the specific movements that each muscle is able to perform. Physiological properties, such as speed of shortening and resistance to fatigue, also vary among skeletal muscles. Another important aspect of muscle diversity concerns the embryological origin: most body muscles derive from somites, but head muscles derive from the presomitic mesoderm. Distinct genetic programs control the development of extraocular and pharyngeal muscles compared to other body muscles (Sambasivan et al., 2009).
Skeletal muscles also differ with respect to the size of the constituent motor units, namely the number of muscle fibers that each motor neuron innervates, and to the functional properties of the motor units. Three types of motor units, called slow, fast fatigable and fast fatigue resistant motor units, composed by type 1, 2A and 2B fibers, respectively, were initially identified in mammalian skeletal muscle (Burke et al., 1971). A fourth motor unit type, composed by type 2X fibers, was subsequently detected in rat skeletal muscles (Larsson et al., 1991b).
At the single fiber level, it is possible to distinguish four major fiber types, called type 1, 2A, 2X and 2B, based on the presence of specific myosin heavy chain (MyHC) isoforms: MyHC-1/slow, coded by the MYH7 gene, MyHC-2A, coded by MYH2, MyHC-2X, coded by MYH1, and MyHC-2B, coded by MYH4 (Schiaffino and Reggiani, 2011). These fibers also differ in oxidative/glycolytic metabolism, type 1 and 2A fibers being more oxidative and type 2B fibers more glycolytic. These four fiber populations are present in mice, rats and many other mammalian species, however only type 1, 2A and 2X fibers are present in most human muscles (Smerdu et al., 1994). In addition, intermediate hybrid fibers, containing type 1 and 2A, or 2A and 2X, or 2X and 2B MyHCs, are frequent in normal muscles (DeNardi et al., 1993) and become more numerous whenever fiber type shifts take place, thus both in response to exercise (Klitgaard et al., 1990) or electrical stimulation (Maier et al., 1988), or during muscle atrophy induced by denervation (Patterson et al., 2006) and other causes (see below). Muscle wasting also leads to an increased proportion of fibers showing a mismatch between the levels of MyHC isoforms revealed by immunohistochemistry and that of the corresponding mRNAs revealed by in situ hybridization, due to the different turnover of the MyHC proteins and transcripts: these mismatched fibers, indicative of muscle fibers in a transitional state, increase after a bed-rest period in human skeletal muscle (Andersen et al., 1999).
Minor fiber types with more restricted distribution in specific muscles can be identified by the presence of distinct MyHCs. A striking case is that of extraocular muscles (EOMs) which contain, in addition to the four major MyHCs, a unique MyHC-EO isoform, coded by MYH13, and the developmental embryonic and neonatal MyHCs, coded by MYH3 and MYH8, respectively (Sartore et al., 1987, Wieczorek et al., 1985), as well as the recently identified MyHC-slow tonic and MyHC15, coded by the MYH7b and MYH15 genes, respectively (Rossi et al., 2010). EOMs are also characterized by the small size of muscle fibers and the regular coexistence of multiple MyHC isoforms within each fiber.
Finally, in addition to the diversity at the whole muscle, motor unit and muscle fiber level, one can identify an additional layer of heterogeneity at the level of the satellite cells. Satellite cells are stem cells with myogenic potential located under the basal lamina of muscle fibers, which can be activated after muscle injury and are responsible for muscle regeneration (Ciciliot and Schiaffino, 2010), and may also be involved in muscle hypertrophy (Pallafacchina et al., 2012). Satellite cells are heterogeneous with respect to embryological origin (somitic vs non-somitic), postnatal stage (young vs old) and muscle type (fast vs slow) (Biressi and Rando, 2010). Satellite cell heterogeneity may affect the muscle regenerative capacity, for example the masseter muscle regenerates less effectively than limb muscles (Pavlath et al., 1998). The existence of intrinsic differences between satellite cells from fast and slow muscles is further suggested by the finding that electrical stimulation of regenerating slow soleus and fast extensor digitorum longus (EDL) muscles with the same slow stimulus pattern in the absence of innervation leads to widespread slow MyHC expression in regenerated soleus but only limited expression of slow MyHC in regenerated EDL (Kalhovde et al., 2005).
Muscle diversity, fiber type diversity and satellite cell diversity may also affect the susceptibility of different muscles and fiber types to disease, including their response to muscle wasting. In this review, we will consider congenital and acquired muscle diseases leading to muscle wasting from the point of view of muscle diversity. We will discuss two related though not necessarily associated changes: (i) muscle wasting conditions involving predominantly atrophy of slow type 1 or fast type 2 muscle fibers and (ii) muscle wasting conditions accompanied by slow-to-fast or fast-to-slow fiber type shift.
Section snippets
Genetic myopathies leading to muscle wasting
Muscular dystrophies affect skeletal muscles differentially (Fig. 1). For example, Duchenne muscular dystrophy (DMD) affects most body muscles, but spares head muscles, including EOMs, which are affected in oculopharyngeal muscular dystrophy. Limb-girdle muscular dystrophy affects proximal, but not distal muscles of the limbs, whereas the opposite is true for the distal forms of muscular dystrophy. Wide variations among muscle types are seen in facioscapulohumeral muscular dystrophy (FSHD):
Acquired muscle wasting syndromes
Muscle wasting occurs in a variety of conditions ranging from muscle disuse to cancer cachexia, from heart failure to aging sarcopenia. In most of these conditions muscle atrophy occurs preferentially in certain fiber types and/or is accompanied by shifts in fiber type profile. Muscle disuse involving loss of neural influence and mechanical loading causes a slow-to-fast shift in fiber type and MyHC isoform profile, usually but not always accompanied by preferential atrophy of type 1 slow fibers
Mechanisms underlying muscle type-specific susceptibility to muscle wasting
Muscle wasting may be the result of a decrease in protein synthesis and an increase in muscle protein breakdown, which in turn reflects the activation of two major pathways, the proteasomal and the autophagic-lysosomal systems (Schiaffino et al., 2013). Both pathways are controlled by the transcription factor FoxO3 (Mammucari et al., 2007, Sandri et al., 2004), which is negatively regulated by Akt, thus fiber type specificity in muscle wasting might be due to differences in the regulation of
Conclusions
The mechanisms responsible for the differential susceptibility of the various muscle types and fiber types to muscle wasting are difficult to dissect, given the variety of conditions and diseases, some of which cause rapid loss of muscle mass, e.g. fasting or disuse, while others develop over months or years, e.g. aging sarcopenia. In addition, the study of many of these conditions is complicated by the multiplicity of local and systemic changes, for example during aging there are changes in
Acknowledgments
Original work reported here has been supported by the EC FP7 Project MYOAGE (grant no. 223576 to SS) and by a grant from the Agenzia Spaziale Italiana (ASI to SS).
References (87)
- et al.
Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia
Cancer Cell
(2005) - et al.
Heterogeneity in the muscle satellite cell population
Seminars in Cell and Developmental Biology
(2010) - et al.
Peroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophy
Journal of Biological Chemistry
(2010) - et al.
IKKbeta/NF-kappaB activation causes severe muscle wasting in mice
Cell
(2004) Congenital fiber-type disproportion
Seminars in Pediatric Neurology
(2011)The muscular dystrophies
Lancet
(2002)- et al.
PGC-1alpha promotes nitric oxide antioxidant defenses and inhibits FOXO signaling against cardiac cachexia in mice
American Journal of Pathology
(2011) - et al.
Skeletal muscle atrophy in old rats: differential changes in the three fiber types
Mechanisms of Ageing and Development
(1991) - et al.
Sparing of extraocular muscle in aging and muscular dystrophies: a myogenic precursor cell hypothesis
Experimental Cell Research
(2011) - et al.
FoxO3 controls autophagy in skeletal muscle in vivo
Cell Metabolism
(2007)
Autophagy is required to maintain muscle mass
Cell Metabolism
Fasting-related autophagic response in slow- and fast-twitch skeletal muscle
Biochemical and Biophysical Research Communications
Hereditary myosin myopathies
Neuromuscular Disorders
Early decrease of IIx myosin heavy chain transcripts in Duchenne muscular dystrophy
Biochemical and Biophysical Research Communications
Proteasome-dependent activation of mammalian target of rapamycin complex 1 (mTORC1) is essential for autophagy suppression and muscle remodeling following denervation
Journal of Biological Chemistry
Distinct regulatory cascades govern extraocular and pharyngeal arch muscle progenitor cell fates
Developmental Cell
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
Cell
The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors
Molecular Cell
Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy
Cell
Mouse skeletal muscle fiber-type-specific macroautophagy and muscle wasting are regulated by a Fyn/STAT3/Vps34 signaling pathway
Cell Reports
Lack of myostatin results in excessive muscle growth but impaired force generation
Proceedings of the National Academy of Sciences of the United States of America
Bed rest increases the amount of mismatched fibers in human skeletal muscle
Journal of Applied Physiology
Denervation effects on myonuclear domain size of rat diaphragm fibers
Journal of Applied Physiology
Histochemical properties of skeletal muscle fibers in streptozotocin-diabetic rats
Cell and Tissue Research
Identification of ubiquitin ligases required for skeletal muscle atrophy
Science
Mammalian motor units: physiological–histochemical correlation in three types in cat gastrocnemius
Science
Myosin and troponin changes in rat soleus muscle after hindlimb suspension
Journal of Applied Physiology
Regeneration of mammalian skeletal muscle. Basic mechanisms and clinical implications
Current Pharmaceutical Design
During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation
Journal of Cell Biology
Structural and functional alterations of muscle fibres in the novel mouse model of facioscapulohumeral muscular dystrophy
Journal of Physiology
Type 2X-myosin heavy chain is coded by a muscle fiber type-specific and developmentally regulated gene
Journal of Cell Biology
Glucocorticoid-induced muscle atrophy prevention by exercise in fast-twitch fibers
Journal of Applied Physiology
Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1
Nature
Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle
Muscle and Nerve
Relationship between cortisone and muscle work in determining muscle size
Journal of Physiology
Atrogin-1 a muscle-specific F-box protein highly expressed during muscle atrophy
Proceedings of the National Academy of Sciences of the United States of America
Muscle fiber composition in patients with traumatic cord lesion
Scandinavian Journal of Rehabilitation Medicine
Glucocorticoids and muscle catabolism
Current Opinion in Clinical Nutrition and Metabolic Care
Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure
Circulation
Muscle atrophy in rats following denervation, casting, inflammation, and tenotomy
Archives of Physical Medicine and Rehabilitation
Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice
Journal of Clinical Investigation
Fast and slow muscle fibres in hindlimb muscles of adult rats regenerate from intrinsically different satellite cells
Journal of Physiology
Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy
Muscle and Nerve
Cited by (399)
Resistance exercise preconditioning prevents disuse muscle atrophy by inhibiting apoptosis and protein degradation via SESN2 in C57BL/6J mice
2024, Biochimica et Biophysica Acta - Molecular Basis of DiseaseExercise couples mitochondrial function with skeletal muscle fiber type via ROS-mediated epigenetic modification
2024, Free Radical Biology and MedicineModerating AKT signaling with baicalein protects against weight loss by preventing muscle atrophy in a cachexia model caused by CT26 colon cancer
2024, Biochimica et Biophysica Acta - Molecular Cell ResearchLower limb suspension induces threshold-specific alterations of motor units properties that are reversed by active recovery
2024, Journal of Sport and Health ScienceCaloric Restriction Rejuvenates Skeletal Muscle Growth in Heart Failure With Preserved Ejection Fraction
2024, JACC: Basic to Translational Science
- ☆
This article is part of a Directed Issue entitled: Molecular basis of muscle wasting.
- 1
These authors contributed equally to this work.
- 2
Present address: Department of Molecular, Cellular and Developmental Biology and BioFrontiers Institute, University of Colorado, Boulder, CO, USA.